There are four global!The only one in Asia, from Tongji!

Tongji

China speed! Tongji power! The doctor should be responsible!

Today's 2022 World Lung Cancer Conference

(WCLC) Concerned in Vienna, the capital of Austria

Shanghai Lung Department, Affiliated to Tongji University

Director of Cancer Department

Tongji University Medical College

Director of Cancer Research Institute

Professor Zhou Cun

Won the Cancer Care Team Award, awarded by the International Cancer Research Association (IASLC), became the only Asian team of the four award -winning teams around the world this year.

The tumor therapy team award is publicly selected by the International Cancer Research Association every year, and aims to recognize the multidisciplinary treatment team of lung cancer in the field of lung cancer and obtain international recognition in the field of lung cancer treatment.

The Zhou Cun team is committed to research on lung cancer targeted therapy, anti -vascular treatment, immunotherapy and clinical transformation. He led the team to establish and improve the method of obtaining lung cancer specimens and molecular types of fast detection paths in China. Patients with lung cancer at the auxiliary Shanghai lung hospital for lung hospitals only need 4 working days from the initial diagnosis to the initial establishment of the treatment plan.

From the establishment of the laboratory, the improvement of the team, the training to the process improvement, etc., with the unremitting exploration and efforts of the team for nearly ten years, this is the high recognition of international peers in the lung cancer diagnosis and treatment system of lung hospitals affiliated to Shanghai. The level of diagnosis and treatment has gone at the forefront of the world.

It is reported that the Zhoucai team has become one of the most important clinical research teams in China. It is more than 30 PI (main research team leader) with more than 30 international and domestic multi -center registered clinical trials. It has participated in more than 50 clinical research. More than 20 projects such as the National 863, the National Natural Science Foundation of China, the Shanghai Science and Technology Commission's major research, and the emerging frontier of Shenkang. Published more than 400 papers in domestic and foreign publications, and edited by the editor -in -chief of multiple academic monographs and obtained a number of invention patents. He has won the second prize of the Chinese Medical Science and Technology Award, the first prize of the Huaxia Medical Science and Technology Award, the first prize of the China Anti -Cancer Association Science and Technology Award, the first prize of the Shanghai Science and Technology Progress Award, and the second prize of the National Science and Technology Progress Award.

Source: Shanghai Lung Department, Affiliated to Tongji University

- END -